Oxidative stress in zinc-induced dopaminergic neurodegeneration: Implications of superoxide dismutase and heme oxygenase-1

Free Radical Research

Volumn 45, Issue 10, 2011, Pages 1207-1222

  Singh, Brajesh Kumar ^a   Kumar, Ashutosh ^a   Ahmad, Israr ^a   Kumar, Vinod ^a   Patel, Devendra Kumar ^a   Jain, Swatantra Kumar ^b   Singh, Chetna ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^b HAMDARD UNIVERSITY   (India)

Author keywords

Heme oxygenase 1; Neurodegeneration; Oxidative stress; Parkinson's disease; Superoxide dismutase; Zinc

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; DOPAMINE; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE TRANSFERASE; HEME OXYGENASE 1; MANGANESE SUPEROXIDE DISMUTASE; TYROSINE 3 MONOOXYGENASE; ZINC;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOPAMINERGIC NERVE CELL; ENZYME ACTIVITY; IMMUNOREACTIVITY; LIPID PEROXIDATION; LOCOMOTION; MALE; MOTOR PERFORMANCE; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; TREATMENT DURATION;

ANIMALS; DOPAMINE; DOPAMINERGIC NEURONS; GLUTAMATE-CYSTEINE LIGASE; HEME OXYGENASE-1; MALE; NERVE DEGENERATION; OXIDATIVE STRESS; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE; ZINC SULFATE;

RATTUS;

EID: 80052693652     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2011.607164     Document Type: Article

References (74)

1. Gorell JM, Johnson CC, Rybicki BA, Peterson EL, Kortsha GX, Brown GG, Richardson RJ. (1997). Occupational exposures to metals as risk factors for Parkinson ' s disease. Neurology 48:650-658. (Pubitemid 27120101)
2. Singh C, Ahmad I, Kumar A. (2007). Pesticides and metals induced Parkinson ' s disease: involvement of free radicals and oxidative stress. Cell Mol Biol (Noisy-le-grand) 53:19-28. (Pubitemid 350164302)
3. Dexter DT, Carayon A, Javoy-Agid F, Agid Y, Wells FR, Daniel SE, (1991) Alterations in the levels of iron, ferritin and other trace metals in Parkinson ' s disease and other neurodegenerative diseases affecting the basal ganglia. Brain 114:1953-1975.
4. Jenner P, Dexter DT, Sian J, Schapira AH, Marsden CD. (1992). Oxidative stress as a cause of nigral cell death in Parkinson ' s disease and incidental Lewy body disease. The royal Kings and Queens Parkinson ' s disease research group. Ann Neurol 32:Suppl S82-7.
5. Kumar A, Ahmad I, Shukla S, Singh BK, Patel DK, Pandey HP, Singh C. (2010). Effect of zinc and paraquat co-exposure on neurodegeneration: Modulation of oxidative stress and expression of metallothioneins, toxicant responsive and transporter genes in rats . Free Radic Res 44:950-965.
6. Takeda A. (2000). Movement of zinc and its functional signifi cance in the brain. Brain Res Rev 34:137-148.
7. Watt NT, Whitehouse IJ, Hooper NM. (2010). The role of zinc in Alzheimer ' s disease. Int J Alzheimers Dis 2011:971021. doi:10.4061/2011/971021.
8. Lin AMY, Fan SF, Yang DM, Hsu LL, Yang CH. (2003). Zincinduced apoptosis in substantia nigra of rat brain: neuroprotection by vitamin D3. Free Radic Biol Med 34:1416-1425. (Pubitemid 36570415)
9. Jomova K, Vondrakova D, Lawson M, Valko M. (2010). Metals, oxidative stress and neurodegenerative disorders. Mol Cell Biochem 345:91-104.
10. Miller RL, James-Kracke M, Sun GY, Sun AY. (2009). Oxidative and infl ammatory pathways in Parkinson ' s disease. Neurochem Res 34:55-65.
11. Martin HM, Teismann P. (2009). Glutathione-a review on its role and signifi cance in Parkinson ' s disease. FASEB J 23:3263-72.
12. Martin LJ. (2010). Mitochondrial and cell death mechanisms in neurodegenerative diseases. Pharmaceuticals (basel) 3:839-915.
13. Lin AMY. (2001). Coexistence of zinc and iron augmented oxidative injuries in the nigrostriatal dopaminergic system of SD rats. Free Radic Biol Med 30:225-231. (Pubitemid 32126442)
14. Hussain S, Ali SF. (2002). Zinc potentiates 1-methyl 1-4-phenyl-1,2,3,6- tetrahydropyridine induced dopamine depletion in caudate nucleus of mice brain. Neurosci Lett 335:25-28. (Pubitemid 35379807)
15. Lo HS, Chiang HC, Lin AMY, Chiang HY, Chu YC, Kao LS. (2004). Synergistic effects of dopamine and Zn2on the induction of PC12 cell death and dopamine depletion in the striatum: possible implication in the pathogenesis of Parkinson ' s disease. Neurobiol Dis 17:54-61. (Pubitemid 39209312)
16. Wu DC, Teismann P, Tieu K, Vila M, Jackson-Lewis V, Ischiropoulos H, Przedborski S. (2003). NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson ' s disease. Proc Natl Acad Sci USA 100:6145-6150. (Pubitemid 36576945)
17. Anantharam V, Kaul S, Song C, Kanthsamy A, Kanthasamy AG. (2007). Pharmacological inhibition of neuronal NADPH oxidase protects against 1-methyl-4-phenylpyridinium (MPP)-induced oxidative stress and apoptosis in mesencephalic dopaminergic neuronal cells. Neurotoxicol 28:988-997. (Pubitemid 47519806)
18. Cristovao AC, Choi DH, Baltazar G, Beal MF, Kim YS. (2009). The role of NADPH oxidase 1-derived reactive oxygen species in paraquat-mediated dopaminergic cell death. Antioxid Redox Signal 11:2105-2118.
19. Pong K, Rong Y, Doctrow SR, Baudry M. (2002). Attenuation of zinc-induced intracellular dysfunction and neurotoxicity by a synthetic superoxide dismutase/catalase mimetic in cultured cortical neurons. Brain Res 950:218-230. (Pubitemid 35253933)
20. Mollace V, Iannone M, Muscoli C, Palma E, Granato T, Rispoli V, et al.(2003). The role of oxidative stress in paraquatinduced neurotoxicity in rats: protection by non peptidyl superoxide dismutase mimetic. Neurosci Lett 335:163-166. (Pubitemid 36071625)
21. Noh KM, Koh JY. (2000). Induction and activation by zinc of NADPH oxidase in cultured cortical neurons and astrocytes. J Neurosci 20 RC111:1-5.
22. Saggu H, Cooksey J, Dexter D, Wells FR, Lees A, Jenner P, Marsden CD. (1989). A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra. J Neurochem 53:692-697. (Pubitemid 19207359)
23. Hung HC, Lee EH. (1998). MPTP produces differential oxidative stress and antioxidative responses in the nigrostriatal and mesolimbic dopaminergic pathways. Free Radic Biol Med 24:76-84. (Pubitemid 28006438)
24. Ren JP, Zhao YW, Sun XJ. (2009). Toxic infl uence of chronic oral administration of paraquat on nigrostriatal dopaminergic neurons in C57BL/6 mice. Chin Med J 122:2366-71.
25. Yu YP, Ju WP, Li ZG, Wang YC, Xie AM. (2010). Acupunture inhibits oxidative stress and rotational behavior in 6-hydroxydopamine lesioned rat. Brain Res 1336:58-65.
26. Schipper HM. (2004). Heme oxygenase expression in human central nervous system disorders. Free Radic Biol Med 37: 1995-2011. (Pubitemid 39491319)
27. Minelli A, Conte C, Grotelli S, Bellezza I, Emiliani C, Bolanos JP. (2009). Cyclo(His-Pro) up-regulates heme oxygenase-1 via activation of Nrf2-ARE signaling. J Neurochem 111: 956-966.
28. Schipper HM, Liberman A, Stopa EG. (1998). Neural heme oxygenase-1 expression in idiopathic Parkinson ' s disease. Exp Neurol 150:60-68. (Pubitemid 28146424)
29. Mateo I, Infante J, Sanchaez-Juan P, Garcia-Gorostiaga I, Rodriquez-Rodriquez E, Vazquez-Hiquera JL, et al. (2010). Serum heme oxygenase-1 levels are increased in Parkinson ' s disease but not in Alzheimer ' s disease. Acta Neurol Scand 121:136-138.
30. Huang JY, Chuang JI. (2010). Fibroblast growth factor 9 upregulates heme oxygenase-1 and gamma glutamylcysteine synthetase expression to protect neurons from 1-methyl-4-phenylpyridinium toxicity. Free Radic Biol Med 49: 1099-1108.
31. Yamamoto N, Izumi Y, Matsuo T, Wakita S, Kume T, Takada-Taktori Y, et al. (2010). Elevation of heme oxygenase-1 by proteasome inhibition affords dopaminergic neuroprotection. J Neurosci Res 88:1934-1942.
32. Infante J, Garcia Gorostiaga I, Sanchez-Juan P, Sierra M, Martin Gurpegu JL, Terrazas J, et al.(2010). Synergistic effect of two oxidative stress-related genes (heme oxygenase-1 and GSK3b) on the risk of Parkinson ' s disease. Eur J Neurol 17:760-762.
33. Jazwa A, Cuadrado A. (2010). Targeting heme-oxygenase-1 for neuroprotection and neuroinfl ammation in neurodegenerative diseases. Curr Drug Targets 11:1517-1531.
34. Sian JP, Dexter DT, Lees AJ, Daniel S, Agid Y, Javoy-Agid F, et al.(1994). Alterations in glutathione levels in Parkinson ' s disease and other neurodegenerative disorders affecting basal ganglia. Ann Neurol 36:348-355. (Pubitemid 24280055)
35. Kang MJ, Gil SJ, Koh HC. (2009). Paraquat induces alteration of the dopamine catabolic pathways and glutathione levels in the substantia nigra of mice. Toxicol Lett 188:148-152.
36. Tsai SJ, Kuo WW, Liu WH, Yin MC. (2010). Antioxidative and anti-infl ammatory protection from carnosine in the striatum of MPTP-treated mice. J Agric Food Chem 58: 11510-11516.
37. Chen CJ, Liao SL. (2003). Zinc toxicity on neonatal cortical neurons: involvement of glutathione chelation. J Neurochem 85:443-453.
38. De La Cruz CP, Revilla E, Steffen V, Rodriguez-Gomez JA, Cano J, Machado A. (1996). Protection of the aged substantia nigra of the rat against oxidative damage by (-)-deprenyl. Br J Pharmacol 117:1756-1760. (Pubitemid 26121622)
39. Chiu K, Lau WM, Lau HT, So KF, Chang RCC. (2007). Micro-dissection of Rat Brain for RNA or Protein Extraction from Specifi c Brain Region. JoVE. 7. doi: 10.3791/269.
40. Singh AK, Tiwari MN, Upadhyay G, Patel DK, Singh D, Prakash O, Singh MP. (2010) Long term exposure to cypermethrin induces nigrostriatal dopaminergic neurodegeneration in adult rats: postnatal exposure enhances the susceptibility during adulthood. Neurobiol Aging Epub ahead of print] doi:10.1016/j. neurobiolaging.2010.02.018.
41. De Vito MJ, Wagner GC. (1989). Functional consequences following methamphetamine induced neuronal damage. Psychopharmacol 97:432-435. (Pubitemid 19102541)
42. Ohkawa H, Ohishi N, Yagi K. (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-358. (Pubitemid 9194347)
43. Ahmad I, Kumar A, Shukla S, Prasad Pandey H, Singh C. (2008). The involvement of nitric oxide in maneb-and paraquat-induced oxidative stress in rat polymorphonuclear leukocytes. Free Radic Res 42:849-862.
44. Sinha AK. (1972). Colorimetric assay of catalase. Anal Chem 47:389-394.
45. Pabst JM, Habig WH, Jakoby WB. (1974). Glutathione-S-transferase A. J Biol Chem 249:7140-7150.
46. Nishikimi M, Appaji N, Yagi K. (1972). The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen. Biochem Biophys Res Commun 46:849-855.
47. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. (1951). Protein measurement with the Folin phenol reagent. J Biol Chem193:265-275.
48. Sugino N, Telleria CM, Gibori G. (1998). Differential regulation of copper-zinc superoxide dismutase and manganese superoxide dismutase in the rat corpus luteum: Induction of manganese superoxide dismutase messenger ribonucleic acid by infl ammatory cytokines. Biol Reprod 59:208-215. (Pubitemid 28304374)
49. Chen CY, Jang JH, Li MH, Surh YJ. (2005). Reserveratrol upregulates heme oxygenase-1 expression via activation of NF-E2-related factor 2 in PC12 cells. Biochem Biophys Res Commun 331:993-1000.
50. Luceri C, Caderni G, Sanna A, Dolara P. (2002). Red wine and black tea polyphenols modulate the expression of cyclooxygenase-2, inducible nitric oxide synthase and glutathione-related enzymes in azoxymethane-induced f344 rat colon tumors. J Nutr 132:1376-1379. (Pubitemid 34606479)
51. Garcon G, Gosset P, Zerimech F, Grave-Descampiaux B, Shirali P. (2004). Effect of Fe 2 O 3 on the capacity of benzo(a) pyrene to induce polycyclic aromatic hydrocarbon-metabolizing enzymes in the respiratory tract of Sprague-Dawley rats. Toxicol Lett 150:179-189. (Pubitemid 38490525)
52. Dexter DT, Wells FR, Lees AJ, Agid F, Agid Y, Jenner P, Marsden CD. (1989). Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson ' s disease. J Neurochem 52:1830-1836. (Pubitemid 19140770)
53. Forsleff L, Schauss AG, Bier ID, Stuart S. (1999). Evidence of functional zinc defi ciency in Parkinson ' s disease. J Altern Complement Med 5:57-64. (Pubitemid 29180801)
54. Jimenez-Jimenez FJ, Fernandez-Calle P, Martinez-Vanaclocha M, Herrero E, Molina JA, Vazquez A, Codoceo R. (1992). Serum, levels of zinc and copper in patients with Parkinson ' s disease. J Neurol Sci 112:30-33.
55. Jimenez-Jimenez FJ, Molina JA, Aguilar MV, Meseguer I, Mateos-Vega CJ, Gonzalez-Munoz MJ, et al. (1998). Cerebrospinal fl uid levels of transition metals in patients with Parkinson ' s disease. J Neural Transm 105:497-505. (Pubitemid 28365032)
56. Patel S, Singh V, Kumar A, Gupta YK, Singh MP. (2006). Status of antioxidant defense system and expression of toxicant responsive genes in striatum of maneb-and paraquatinduced Parkinson ' s disease phenotype in mouse: mechanism of neurodegeneration. Brain Res 1081:9-18.
57. Thiruchelvam M, McCormack A, Richfi eld EK, Baggs RB, Tank AW, Di Monte DA, Cory-Slechta DA. (2003). Agerelated irreversible progressive nigrostriatal dopaminergic neurotoxicity in the paraquat and maneb model of the Parkinson ' s disease phenotype. Eur J Neurosci 18:589-600. (Pubitemid 37045378)
58. Singh S, Singh K, Patel S, Patel DK, Singh C, Nath C, Singh MP. (2008). Nicotine and caffeine-mediated modulation of toxicant responsive genes and vesicular monoamine transporter-2 in 1-methyl 4-phenyl-1,2,3,6- tetrahydropyridineinduced Parkinson ' s disease phenotype in mouse. Brain Res 1207:193-206.
59. Gupta SP, Patel S, Yadav S, Singh AK, Singh S, Singh MP. (2010). Involvement of nitric oxide in maneb-and paraquatinduced Parkinson ' s disease phenotype in mouse: is there any link with lipid peroxidation? Neurochem Res 35:1206-1213.
60. Miller RL, Sun GY, Sun AY. (2007). Cytotoxicity of paraquat in microglial cells: involvement of PKCdelta-and ERK1/2-dependent NADPH oxidase. Brain Res 1167:129-139. (Pubitemid 47302435)
61. Kunikowska G, Jenner P. (2003). Alterations in m-RNA expression for Cu, Zn-superoxide dismutase and glutathione peroxidase in the basal ganglia of MPTP-treated marmosets and patients with Parkinson ' s disease. Brain Res 968: 206-218. (Pubitemid 36349679)
62. Cadet JL, Sheng P, Ali S, Rothman R, Carlson E, Epstein C. (1994). Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice. J Neurochem 62:380-383.
63. Thiruchelvam M, Prokopenko O, Cory-Slechta DA, Buckley B, Mirochnitchenko O. (2005). Overexpression of superoxide dismutase or glutathione peroxidase protects against the paraquatmaneb-induced Parkinson disease phenotype. J Biol Chem 280:22530-22539. (Pubitemid 40827911)
64. Peng J, Stevenson FF, Doctrow SR, Andersen JK. (2005). Superoxide dismutase/catalase mimetics are neuroprotective against selective paraquat-mediated dopaminergic neuron death in the substantial nigra: implications for Parkinson disease. J Biol Chem 280:29194-29198. (Pubitemid 41161371)
65. Lessner G, Schmitt O, Haas SJ, Mikkat S, Kreutzer M, Wree A, Glocker MO. (2010). Differential proteome of the striatum from hemiparkinsonian rats displays vivid structural remodeling processes. J Proteome Res 9:4671-4687.
66. Kauppinen TM, Higashi Y, Suh SW, Escartin C, Nagasawa K, Swanson RA. (2008). Zinc triggers microglial activation. J Neurosci 28:5827-5835.
67. Hung SY, Liou HC, Kang KH, Wu RM, Wen CC, Fu WM. (2008). Overexpression of heme oxygenase-1 protects dopaminergic neurons against 1-methyl-4- phenylpyridinium-induced neurotoxicity. Mol Pharmacol 74:1564-1575.
68. Quesada A, Micevvch P, Handforth A. (2009). C-terminal mechano growth factor protects dopamine neurons: a novel peptide that induces heme oxygenase-1. Exp Neurol 220:255-266.
69. Barlow BK, Lee DW, Cory-Slechta DA, Opanashuk LA. (2005). Modulation of antioxidant defense system by the environmental pesticide maneb in dopaminergic cells. Neurotoxicol 26:63-75. (Pubitemid 39440966)
70. Yang W, Tiffany-Castiglioni E. (2005). The bipyridyl herbicide paraquat produces oxidative stress-mediated toxicity in human neuroblastoma SH-SY5Y cells: relevance to the dopaminergic pathogenesis. J Toxicol Environ Health A 68:1939-1961. (Pubitemid 41765788)
71. Noriega GO, Gonzales S, Tomaro M, Battle AMDC. (2002). Paraquat-generated oxidative stress in rat liver induces hemeoxygenase-1 and aminolevulinic acid synthase. Free Radic Res 36:633-639. (Pubitemid 34567336)
72. Smeyne M, Boyd J, Shepherd KR, Jiao Y, Pond BB, Hatler M, et al. (2007). GST expression mediates dopaminergic neuron sensitivity in experimental parkinsonism. Proc Natl Acad Sci 104:1977-1982. (Pubitemid 46239889)
73. Shi M, Bradner J, Bammler TK, Wilson AM, Montine TJ, Pan C, Zhang J. (2009). Identifi cation of glutathione S-transferase pi as a protein involved in Parkinson disease progression. Am J Pathol 175:54-65.
74. Garcia JC, Remires D, Leiva A, Gonzalez R. (2000). Depletion of brain glutathione potentiates the effect of 6-hydroxydopamine in a rat model of Parkinson ' s disease. J Mol Neurosci 14:147-153. (Pubitemid 30660804)